Inducible Escherichia coli fermentation for increased plasmid DNA production

被引:62
作者
Carnes, Aaron E. [1 ]
Hodgson, Clague P. [1 ]
Williams, James A. [1 ]
机构
[1] Nat Technol Corp, Lincoln, NE 68521 USA
关键词
DNA vaccine; Escherichia coli; fermentation; gene therapy; plasmid DNA; vector;
D O I
10.1042/BA20050223
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bacterial plasmids are the vectors of choice for DNA vaccines and short-term gene therapeutics. Growing plasmid DNA by microbial (Escherichia coli) fermentation is usually combined with alkaline lysis/chromatography methods of purification. To date, typical plasmid fermentation media and processes result in yields of 100-250 mg of plasmid DNA/I of culture medium, using standard high-copy pUC origin-containing plasmids. In order to address this initial and yield-limiting upstream step, we identified novel fermentation control parameters for fed-batch fermentation. The resulting fermentation strategies significantly increased specific plasmid yield with respect to cell mass while enhancing plasmid integrity and maintaining supercoiled DNA content. Fed-batch fermentation yield exceeding 1000 mg of plasmid DNA/I was obtained after reduction of plasmid-mediated metabolic burden during growth, and yields up to 1500 mg of plasmid DNA/I have been achieved with optimized plasmid backbones. Interestingly, by inducing high plasmid levels after sufficient biomass accumulation at low temperature and restricted growth, cells were able to tolerate significantly higher plasmid quantities than cells grown by conventional processes. This S-10-fold increase in plasmid yield dramatically decreases plasmid manufacturing costs and improves the effectiveness of downstream purification by reducing the fraction of impurities.
引用
收藏
页码:155 / 166
页数:12
相关论文
共 47 条
[1]   Inhibiting cell division in Escherichia coli has little if any effect on gene expression [J].
Arends, SJR ;
Weiss, DS .
JOURNAL OF BACTERIOLOGY, 2004, 186 (03) :880-884
[2]   PLASMID PRESENCE CHANGES THE RELATIVE LEVELS OF MANY HOST-CELL PROTEINS AND RIBOSOME COMPONENTS IN RECOMBINANT ESCHERICHIA-COLI [J].
BIRNBAUM, S ;
BAILEY, JE .
BIOTECHNOLOGY AND BIOENGINEERING, 1991, 37 (08) :736-745
[3]  
Carnes A. E., 2005, BIOPROCESS INT, V3, P36
[4]  
CHEN W, 1999, Patent No. 5955323
[5]   Enhanced production of insulin-like growth factor I fusion protein in Escherichia coli by coexpression of the down-regulated genes identified by transcriptome profiling [J].
Choi, JH ;
Lee, SJ ;
Lee, SJ ;
Lee, SY .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2003, 69 (08) :4737-4742
[6]   Optimizing alkaline lysis for DNA plasmid recovery [J].
Clemson, M ;
Kelly, WJ .
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2003, 37 :235-244
[7]  
DIAZ RJC, 2000, CRIT REV BIOTECHNOL, V20, P790
[8]  
Doolan DL, 2002, CHEM IMMUNOL, V80, P308
[9]   Manufacturing and quality control of plasmid-based gene expression systems [J].
Durland, RH ;
Eastman, EM .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 30 (1-3) :33-48
[10]  
*FDA, 1996, POINTS CONS PASM DNA